The abstract is read at the publisher; the summary is JClub's.
DAA treatment after HCV replicon suppression only partially restores epithelial organization in Huh7-R spheroids, leaving actin-rich protrusions at 25% versus 2.5% in controls.
- Why it matters: Even after DAAs eradicate HCV, fibrosis progression and hepatocellular carcinoma risk can persist, implying incomplete recovery of hepatocyte differentiation and identity programs.
- What they did: Huh7 and Huh7-R cells were grown in 3D Matrigel and assessed for spheroid morphology, polarity features, EMT markers, and transcriptomic signatures after sofosbuvir with or without velpatasvir, plus analysis of biopsy data before therapy and within five days after completion.
- The result: EMT scoring and lipid metabolism/differentiation gene dysregulation persist in DAA-treated cells and in end-of-treatment patient biopsies, suggesting cellular plasticity and metabolic reprogramming may remain after cure.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.